About this FactMed analysis covering adverse side effect reports of ADDAMEL patients who developed BRONCHOPNEUMONIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 3 individuals taking ADDAMEL reported BRONCHOPNEUMONIA to the FDA. A total of 12 ADDAMEL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ADDAMEL and BRONCHOPNEUMONIA. In doing so, we compare ADDAMEL with other drugs that cause BRONCHOPNEUMONIA, to help you evaluate whether or not ADDAMEL causes BRONCHOPNEUMONIA. Likewise, this page shows the most highly-reported side effects of ADDAMEL, so you can see if BRONCHOPNEUMONIA ranks among ADDAMEL's most well-known side effects.
Summary Statistics
Reports of ADDAMEL causing BRONCHOPNEUMONIA: 3
Reports of any side effect of ADDAMEL : 12
Percentage of ADDAMEL patients where BRONCHOPNEUMONIA is a reported side effect: 25.0000%

FDA reports of any drug causing BRONCHOPNEUMONIA : 3987
Average percentage for all medicated patients where BRONCHOPNEUMONIA is reported as a complication: 0.0250%

Physician opinion on ADDAMEL as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ADDAMEL:
DRUG USE FOR UNKNOWN INDICATION ( 3 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 1 patients )
VITAMIN SUPPLEMENTATION ( 1 patients )
PROPHYLAXIS ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with BRONCHOPNEUMONIA:

ASPIRIN (383 patients)
METHOTREXATE (382 patients)
HUMIRA (299 patients)
PREDNISOLONE (280 patients)
FUROSEMIDE (270 patients)
OMEPRAZOLE (268 patients)
PREDNISONE (259 patients)
ACETAMINOPHEN (236 patients)
FOLIC ACID (223 patients)
LASIX (176 patients)
REMICADE (170 patients)
DEXAMETHASONE (148 patients)
ALLOPURINOL (148 patients)
VIOXX (147 patients)
NEXIUM (129 patients)
REVLIMID (129 patients)
MORPHINE (119 patients)
SIMVASTATIN (118 patients)
FOSAMAX (114 patients)
FORTEO (109 patients)
ENBREL (106 patients)
ALBUTEROL (106 patients)
DIAZEPAM (105 patients)
CYCLOSPORINE (103 patients)
ATENOLOL (102 patients)
LORAZEPAM (102 patients)
VELCADE (101 patients)
CYCLOPHOSPHAMIDE (100 patients)
CISPLATIN (100 patients)
LEVOTHYROXINE SODIUM (96 patients)
CIPROFLOXACIN (95 patients)
CLOZARIL (95 patients)
ZOCOR (92 patients)
SYNAGIS (90 patients)
MAGNEVIST (89 patients)
AMLODIPINE (89 patients)
SINGULAIR (88 patients)
DIGOXIN (86 patients)
LANSOPRAZOLE (84 patients)
METHYLPREDNISOLONE (79 patients)
OXYCODONE HCL (79 patients)
SPIRONOLACTONE (78 patients)
ZOMETA (78 patients)
IBUPROFEN (78 patients)
DURAGESIC-100 (78 patients)
AMBIEN (76 patients)
POTASSIUM CHLORIDE (76 patients)
VANCOMYCIN (75 patients)
PARACETAMOL (75 patients)
AMOXICILLIN (74 patients)
METFORMIN HCL (72 patients)
XANAX (72 patients)
HYDROCHLOROTHIAZIDE (71 patients)
METHADONE HCL (71 patients)
DECADRON (69 patients)
LEVAQUIN (69 patients)
PREDNISONE TAB (69 patients)
ZOFRAN (66 patients)
ENALAPRIL MALEATE (66 patients)
FLUOROURACIL (66 patients)
BISOPROLOL FUMARATE (66 patients)
TRAMADOL HCL (66 patients)
PRILOSEC (65 patients)
VICODIN (65 patients)
RAMIPRIL (64 patients)
PERCOCET (64 patients)
ACYCLOVIR (63 patients)
LISINOPRIL (63 patients)
LUCENTIS (62 patients)
MYCOPHENOLATE MOFETIL (62 patients)
COMPAZINE (61 patients)
INSULIN (61 patients)
VINCRISTINE (61 patients)
ENOXAPARIN SODIUM (61 patients)
OXYCONTIN (60 patients)
AVELOX (60 patients)
CLOZAPINE (59 patients)
LYRICA (58 patients)
NEURONTIN (58 patients)
LIPITOR (58 patients)
COUMADIN (58 patients)
RITUXIMAB (58 patients)
LANTUS (58 patients)
HEPARIN SODIUM INJECTION (58 patients)
AVONEX (58 patients)
ACTOS (57 patients)
AREDIA (57 patients)
SPIRIVA (56 patients)
ATROVENT (56 patients)
MEDROL (55 patients)
SYMBICORT (55 patients)
DIOVAN (55 patients)
AMITRIPTYLINE HCL (54 patients)
ROCEPHIN (54 patients)
SEROQUEL (54 patients)
BICILLIN /00026701/ (54 patients)
CLARITHROMYCIN (53 patients)
AUGMENTIN '125' (53 patients)
METOCLOPRAMIDE (52 patients)
PROTONIX (52 patients)
MORPHINE SULFATE (51 patients)
THALIDOMIDE (51 patients)
FLAGYL (50 patients)
PROZAC (50 patients)
CLONAZEPAM (50 patients)
NORVASC (50 patients)
FLUCONAZOLE (50 patients)
ALENDRONATE SODIUM (50 patients)
PLAQUENIL (49 patients)
DOXORUBICIN HCL (49 patients)
ZYPREXA (49 patients)
WARFARIN SODIUM (48 patients)
ZOLOFT (48 patients)
TOPROL-XL (47 patients)
CALCIUM CARBONATE (47 patients)
PERIDEX (47 patients)
LACTULOSE (46 patients)
RANITIDINE (46 patients)
TYSABRI (44 patients)
PANTOPRAZOLE SODIUM (44 patients)
TEMAZEPAM (44 patients)
OXYGEN (44 patients)
FENTANYL (43 patients)
MABTHERA (43 patients)
PRAVACHOL (42 patients)
LEFLUNOMIDE (42 patients)
CARBOPLATIN (42 patients)
BEXTRA (42 patients)
LOSARTAN POTASSIUM (41 patients)
RABEPRAZOLE SODIUM (41 patients)
ATORVASTATIN CALCIUM (41 patients)
KETOPROFEN (40 patients)
DILAUDID (40 patients)
FLEXERIL (40 patients)
ALPRAZOLAM (40 patients)
LORTAB (40 patients)
PANTOPRAZOLE (39 patients)
RISPERDAL (39 patients)
TORSEMIDE (39 patients)
CLOPIDOGREL (38 patients)
GABAPENTIN (38 patients)
LIDODERM (38 patients)
COREG (38 patients)
AMIODARONE HCL (38 patients)
AZATHIOPRINE (38 patients)
FERROUS SULFATE TAB (37 patients)
BONIVA (37 patients)
METOPROLOL TARTRATE (37 patients)
LENALIDOMIDE (37 patients)
MOBIC (37 patients)
LOMOTIL (37 patients)
MELOXICAM (36 patients)
ADVAIR DISKUS 100/50 (36 patients)
CALCIUM (36 patients)
EXELON (36 patients)
IRESSA (35 patients)
RADIOTHERAPY (35 patients)
FLONASE (35 patients)
CYTOXAN (35 patients)
DARBEPOETIN ALFA (35 patients)
NEVIRAPINE (35 patients)
FLUOXETINE (35 patients)
MULTI-VITAMINS (34 patients)
MYCOSTATIN (34 patients)
CLINDAMYCIN (34 patients)
MS CONTIN (34 patients)
LEVOFLOXACIN (34 patients)
NYSTATIN (34 patients)
CYMBALTA (34 patients)
SULFASALAZINE (34 patients)
ASACOL (34 patients)
OXALIPLATIN (34 patients)
AMLODIPINE BESYLATE (34 patients)
INVANZ (33 patients)
DICLOFENAC SODIUM (33 patients)
METOPROLOL SUCCINATE (33 patients)
CAPTOPRIL (33 patients)
DARVOCET-N 100 (33 patients)
AVANDIA (33 patients)
CEFTIN (33 patients)
DIFLUCAN (33 patients)
SODIUM CHLORIDE (33 patients)
ZOVIRAX (33 patients)
IMURAN (33 patients)
KEFLEX (32 patients)
COTRIM (32 patients)
KALETRA (32 patients)
ISONIAZID (32 patients)
MIRTAZAPINE (32 patients)
ZANTAC (31 patients)
HYDROCODONE (31 patients)
SYNTHROID (31 patients)
FLOVENT (31 patients)
HALOPERIDOL (31 patients)
HUMALOG (31 patients)
DOCETAXEL (31 patients)
ONDANSETRON (30 patients)
TRAZODONE HCL (30 patients)
ZYVOX (30 patients)
VITAMIN B-12 (30 patients)
AGRYLIN (30 patients)
TYLENOL (CAPLET) (30 patients)
TAGAMET (29 patients)
MEPRON (29 patients)
ETOPOSIDE (29 patients)
BELLERGAL (29 patients)
RAPAMUNE (29 patients)
VITAMIN D (29 patients)
SERETIDE (29 patients)
EVISTA (29 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ADDAMEL


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about BRONCHOPNEUMONIA and ADDAMEL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ADDAMEL, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ADDAMEL. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ADDAMEL experts. If you are a healthcare provider experienced in prescribing ADDAMEL, please register here.
giCould not connect: